Zamboni W A, Fisher K S, Ross D S
Department of Surgery, Southern Illinois University School of Medicine, Springfield 62794-9230.
Postgrad Med J. 1991 Apr;67(786):362-5. doi: 10.1136/pgmj.67.786.362.
A review of 122 patients treated for pancreatic adenocarcinoma from January 1978 through December 1984 was accomplished to determine patient survival and the effect of surgical palliation. One hundred patients underwent laparotomy, including biopsy only (n = 42), biliary bypass (n = 30), gastric bypass (n = 1), biliary and gastric bypass (n = 14), and curative resection (n = 13). Total patient median survival was 3.6 months and no patient lived 5 years. No significant difference in survival was found between the biliary bypass and combined biliary-gastric bypass groups. Only 1 of 30 patients (3.3%) undergoing biliary bypass alone without evidence of pre-operative gastric outlet obstruction developed late gastric outlet obstruction requiring gastrojejunostomy. Operative time and postoperative morbidity were greater in the biliary-gastric bypass group. These results do not support routine prophylactic use of gastrojejunostomy at the time of biliary bypass for patients with unresectable carcinoma of the pancreas.
对1978年1月至1984年12月期间接受治疗的122例胰腺腺癌患者进行了回顾性研究,以确定患者的生存率以及手术姑息治疗的效果。100例患者接受了剖腹手术,包括仅活检(n = 42)、胆管搭桥术(n = 30)、胃搭桥术(n = 1)、胆管和胃搭桥术(n = 14)以及根治性切除术(n = 13)。患者的总中位生存期为3.6个月,无患者存活5年。胆管搭桥术组和胆管 - 胃联合搭桥术组之间的生存率无显著差异。在30例仅接受胆管搭桥术且术前无胃出口梗阻证据的患者中,只有1例(3.3%)出现了晚期胃出口梗阻,需要进行胃空肠吻合术。胆管 - 胃搭桥术组的手术时间和术后发病率更高。这些结果不支持对无法切除的胰腺癌患者在进行胆管搭桥术时常规预防性使用胃空肠吻合术。